Key facts
- It has raised $49.8M; the latest was Later Stage VC ($13.5M) in Mar 2026.
- Notable investors include SBI Investment, StartX (US), KB Investment, Korea Development Bank, Matter (Consulting Services (B2B)) — 25 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 25 names
- ·Watchlist + deal alerts for Mediwhale
- ·The full record, as it builds
Funding rounds
No funding rounds for Mediwhale are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mediwhale
Developer of artificial intelligence-based diagnostics designed to predict health risks through retinal scans. The company's platform offers early detection of cardiovascular, kidney, and eye diseases, enabling doctors to provide preventive healthcare in primary care settings.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2016
- Employees
- 18
- Website
- mediwhale.com/
- Ownership
- Privately Held (backing)
Mediwhale doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mediwhale shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mediwhale in its N-PORT filings yet. We sweep new filings monthly.